Dipexium announces top-line data from OneStep phase 3 trials with Locilex®
Dipexium announced that the OneStep-1 and OneStep-2 Phase 3 clinical trials of Locilex® (pexiganan cream 0.8%) in patients with mild infections of diabetic foot ulcers did not meet the primary clinical endpoint of superiority versus vehicle plus standardized wound care. October 25, 2016